EASL Liver Cancer Summit

EASL Liver Cancer Summit focuses on Preclinical research on the mechanisms of malignant transformation of hepatic cells and of cell-to-cell interactions, Basic and translational research on the biology, genetics, and immunology of HCC and CCA, New developments in HCC and CCA management, including new targeted agents and recent data and implications for immunotherapy of HCC and CCA, Personalized medicine, The new challenge of microbiota and liver cancer, Novel biomarker concepts in HCC and CCA, Discussions on clinical trials between academia, pharma and regulatory agencies and etc.